Search for other papers by Annabel S Jones in
Google Scholar
PubMed
Search for other papers by Annabelle M Warren in
Google Scholar
PubMed
Department of Medicine (Alfred), Monash University, Melbourne, Australia
Search for other papers by Leon A Bach in
Google Scholar
PubMed
Department of Medicine (Alfred), Monash University, Melbourne, Australia
Womens’ Health Research Program, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
Search for other papers by Shoshana Sztal-Mazer in
Google Scholar
PubMed
Availability in Australia IV Calcitriol 1 µg IV every 4 days 0.25 µg IV daily $120 $480 Available IV Calcium gluconate 4.4 mmol IV 5x daily 4.4 mmol IV 3x daily $1674 $1004 Available Teriparatide (PTH 1–34) 20 µg subcut twice
Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
School of Medicine, University of Western Australia, Nedlands, Western Australia, Australia
Search for other papers by Bronwyn G A Stuckey in
Google Scholar
PubMed
Search for other papers by James D Nolan in
Google Scholar
PubMed
Search for other papers by David M Hurley in
Google Scholar
PubMed
Search for other papers by Graeme B Martin in
Google Scholar
PubMed
age of 12 months, he received a 2-month course of pulsatile GnRH therapy. The clinical protocol was as follows. A saline solution of GnRH (Gonadorelin, Ayerst Australia, Pty Ltd, West Ryde, NSW, Australia) was delivered as a pulse every 60–90 minutes
Search for other papers by Melissa Katz in
Google Scholar
PubMed
School of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia
Search for other papers by Simon Smith in
Google Scholar
PubMed
School of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia
Search for other papers by Luke Conway in
Google Scholar
PubMed
School of Medicine and Dentistry, James Cook University, Cairns, Queensland, Australia
Search for other papers by Ashim Sinha in
Google Scholar
PubMed
empirical management is initiated in those at risk living in endemic areas. The case A 30-year-old Caucasian stay-at-home mother presented to our hospital in northern Australia with a 1-week history of undifferentiated abdominal pain and fevers. She
University of Adelaide, Adelaide, South Australia, Australia
Search for other papers by Annabelle G Hayes in
Google Scholar
PubMed
University of Adelaide, Adelaide, South Australia, Australia
Search for other papers by Mahesh M Umapathysivam in
Google Scholar
PubMed
University of Adelaide, Adelaide, South Australia, Australia
Search for other papers by David J Torpy in
Google Scholar
PubMed
hypoglycaemia associated with ingesting counterfeit medication . Medical Journal of Australia 2010 192 716 – 717 . ( https://doi.org/10.5694/j.1326-5377.2010.tb03710.x ) 10.5694/j.1326-5377.2010.tb03710.x 10 Al-Kuraishy HM Al-Gareeb AI . Erectile
Search for other papers by Chelsea Tan in
Google Scholar
PubMed
Search for other papers by Jessica Triay in
Google Scholar
PubMed
interference ( 7 ). Its high cost in Australia was a limiting factor for initial use in this case. Due to its synergistic effect with ketoconazole, metyrapone at an initial dose of 750 mg TDS would have been the preferred second-line agent to achieve a target
Search for other papers by Shamil D Cooray in
Google Scholar
PubMed
Department of Medicine, Monash University, Melbourne, Australia
Search for other papers by Duncan J Topliss in
Google Scholar
PubMed
radiotherapy had good effect with resolution of the patient’s right flank pain and right lower limb numbness. Two months later, sorafenib received approval for use in Australia and was commenced at a dose of 200 mg po BD. Outcome and follow-up Two
Search for other papers by Niamh O’Donnell in
Google Scholar
PubMed
Search for other papers by Aisling McCarthy in
Google Scholar
PubMed
Search for other papers by Ken Thong in
Google Scholar
PubMed
. Endocrinology, Diabetes and Metabolism Case Reports 2013 8 130008. ( https://doi.org/10.1530/EDM-13-0008.3 ) 4 Smithson J Drug induced muscle disorders . Australian Pharmacist 2009 28 1056 – 1062 . 5 Salvatore D Simonides WS Dentice M